GSK signs deal for smoking vaccine Nov 17, 2009
Glaxo in deal with Marylands Nabi Biopharmaceuticals with $500M potential - Triangle Business Journal ... Glaxo in deal with Marylands Nabi Biopharmaceuticals with $500M potential. (Triangle Business Journal)
Drug may help smokers kick butts Nov 10, 2009
The , a division of the , gave Nabi BioPharmaceuticals a $10 million grant to take its anti-nicotine vaccine, NicVAX, to Phase III clinical trials. According to the National Institutes of Health, in Phase III trials, the treatment is "given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely." It's also the last step before the drug can go before the... (CNN)
U.S. Backs Vaccines for Drug, Nicotine Addiction Oct 22, 2009
Earlier this month, her agency, part of the National Institutes of Health, awarded Nabi Biopharmaceuticals a $10 million grant -- the agency's largest ever -- for a late-stage clinical trial of Nabi's vaccine for nicotine addiction called NicVAX.. Volkow said she did her homework before backing the Nabi vaccine to ensure it was significantly different from other products. (MEDLINEplus)
Stop-Smoking Vaccine in the Works Oct 14, 2009
Nabi Biopharmaceuticals of Rockville will launch a phase III study of a potential vaccine called NicVAX. The study, which could be the last step of research if the vaccine works, represents the most advanced investigation of a smoking-cessation vaccine. The vaccine is designed to help people quit smoking and not relapse. (MEDLINEplus)
Glaxo Buys Nabi Staph Infection Vaccine for $46M Aug 7, 2009
Nabi Biopharmaceuticals said Thursday it sold its staph infection vaccine PentaStaph to British drugmaker GlaxoSmithKline PLC in a deal worth as much as $46 million. Nabi said it will receive $20 million upfront, with the rest of the payments depending on four undisclosed milestones being accomplished. (ABC News -- Wire)
Biotechs go without CFOs in midst of economic recession Mar 13, 2009
Nabi Biopharmaceuticals. Former CFO: Jordan Siegel. (Washington Business Journal, DC)
